Fingerprint
Dive into the research topics of 'A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically